Naphthalocyanine complexes as potential photosensitizers for photodynamic therapy of tumors

Journal of Biomedical Optics

Volumn 4, Issue 3, 1999, Pages 276-285

  Shopova, M ^a   Woehrle, D ^b   Mantareva, V ^a   Mueller, S ^b  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG DOSAGE; LASER APPLICATIONS; NITROGEN COMPOUNDS; ONCOLOGY; PATIENT TREATMENT; PHARMACOKINETICS; PHOTOSENSITIZERS; TISSUE;

NAPHTHALOCYANINE; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 0032599391     PISSN: 10833668     EISSN: None     Source Type: Journal    
DOI: 10.1117/1.429930     Document Type: Article

References (25)

1. T. J. Dougherty, "Yearly review: Photodynamic therapy," Photochem. Photobiol. 58, 895-900 (1993).
2. C. J. Gomer, "Photodynamic therapy in the treatment of malignancies," Sem. Hematol. 26, 27-34 (1989).
3. Y. Hayata, H. Kato, C. Konaka, T. Okunaka, and K. Furukawa, "Overview of clinical PDT," in Photodynamic Therapy and Biomedical Lasers, pp. 1-5, Elsevier, Amsterdam (1992).
4. D. Kessel, "HpD: structure and determination of localization," in Photodynamic Therapy of Neoplastic Disease, Vol. 2, pp. 1-14 CRC Press, Boca Raton (1990).
5. P. A. Firey, W. E. Ford, J. R. Sounik, M. E. Kenney, and M. A. J. Rodgers, "Silicon naphthalocyanine triplet state and oxygen: a reversible energy-transfer reaction," J. Am. Chem. Soc. 110, 7626-7630 (1988).
6. G. Jori, L. Tomio, and E. Reddi, "Preferential delivery of liposome incorporated porphyrins to neoplastic cells in tumor bearing rats," Br. J. Cancer 48, 307-309 (1983).
7. D. Woehrle, M. B. Shopova, S. Mueller, A. Milev, V. N. Mantareva, and K. Krastev, "Liposome delivered Zn(III)-2,3-naphthalocyanines as potential sensitizers for PDT: synthesis, photochemical, pharmacokinetic, and phototherapeutic study," J. Photochem. Photobiol., B 21, 155-165 (1993).
8. C. V. Schoenermark, A. Volker, S. Muelle, D. Woehrle, and B. Roeder, "Spectroscopic studies on Si-phthalocyanines and Si-naphthalocyanines," in Photodynamic Therapy of Cancer II, Proc. SPIE 2325, 339-348 (1994).
9. S. A. Mikhalenko and E. A. Lukyanets, "Phthalocyanines and related compounds. II Sythesis and certan properties of 2,3-naphthalocyanines," Zh. Obshch. Khim. 39, 2554-2558 (1969).
10. D. Woehrle, G. Krawczyk, and M. Paliuras, "Polymeric bound porphyrins and their precursors, 6. Synthesis of water-soluble, negatively or uncharged polymers with covalently bound moities of porphyrin derivatives," Makromol. Chem. 189, 1001-1011 (1988).
11. V. N. Korpanenkov, E. A. Makarova, and E. A. Lukyanets, "Synthesis of 6,7-substituted 2-Naphtols," Zh. Org. Khim. 17, 358-361 (1981).
12. V. Cuomo, G. Jori, B. Rihter, M. E. Kenney, and M. A. J. Rodgers, "Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitizer for experimental tumors: Pharmacokinetic and phototherapeutic studies," Br. J. Cancer 62, 966-970 (1990).
13. M. Soncin, L. Polo, E. Reddi, G. Jori, M. E. Kenny, S. Chang, and M. A. J. Rodgers, "Effect of axial ligation and delivery system on the tumor-localizing and photosensitizing properties of Ge(IV)-octabutoxy-phthalocyanines," Br. J. Cancer 71, 727-731 (1995).
14. M. B. Shopova, V. N. Mantareva, K. Krastev, D. Hadjiolov, A. Milev, K. Spirov, G. Jori, and F. Ricchelli, "Comparative pharmacokinetic and photodynamic studies with Zn(II)-phthalocyanine in hamster bearing an induced or transplanted DMBA-rhabdomyosarcoma," J. Photochem. Photobiol., B 16, 83-89 (1992).
15. R. Biolo, G. Jori, M. Soncin, R. Pratesi, U. Vanni, B. Rihter, M. E. Kenney, and M. A. J. Rodgers, "Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine," Photochem. Photobiol. 59, 362-365 (1994).
16. R. Biolo, G. Jori, M. Soncin, B. Rihter, M. E. Kenny, and M. A. J. Rodgers, "Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice," Photochem. Photobiol. 63(2), 224-228 (1996).
17. M. Leunig, A. Leunig, P. Lankes, and A. E. Goetz, "Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumor eradication," Int. J. Hyperthermia 10, 297-306 (1994).
18. N. Michailov, M. Peeva, I. Angelov, D. Woehrle, S. Mueller, G. Jori, F. Ricchelli, and M. Shopova, "Fluence rate effects on photodynamic therapy of B16 pigmented melanoma," J. Photochem. Photobiol., B 37, 147-154 (1997).
19. P. J. Bugelski, C. W. Porter, and T. J. Dougherty, "Autoradiographic distribution of HpD in normal and tumor tissue of the mouse," Cancer Re. 41, 4606-4612 (1981).
20. E. Reddi, C. Zhou, R. Biolo, E. Menegaldo, and G. Jori, "Liposome-or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumors I. Pharmacokinetic properties and phototherapeutic efficiency," Br. J. Cancer 61, 407-411 (1990).
21. G. Jori, "In vivo transport and pharmacokinetic behaviour of tumor photosensitizers," in Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use, Ciba Foundation Symposium, Vol. 146, pp, 78-94, Wiley, Chichester (1989).
22. 2," in Photodynamic therapy: Mechanisms II, Proc. SPIE 1203, 118-125 (1990).
23. J. C. Maziere, P. Morliere, and R. Santus, "The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers for the photodynamic therapy of tumors," J. Photochem. Photobiol., B 8, 315-360 (1991).
24. L. O. Svaasand, E. Martinelli, C. J. Gomer, and E. A. Profio, "Optical characteristics of intraocular tumors in the visible and near-infrared," in Photodynamic therapy: Mechanisms II, Proc. SPIE 1203, 2-21 (1990).
25. 1 variant," Cancer Lett. (Shannon, Ireland) 24, 57-63 (1984).